Vereinbaren Sie ein Beratungsgespräch über Stammzellen
Mehr erfahren
Kontaktieren Sie uns noch heute!
Möchten Sie mehr über unsere Dienstleistungen erfahren? Füllen Sie das untenstehende Formular aus, und wir werden uns so schnell wie möglich mit Ihnen in Verbindung setzen, um Ihnen alle notwendigen Informationen zu geben und Ihre Fragen zu beantworten.
Liste der Verwendungen von Stammzellen, die von den Laboren der FamiCord-Gruppe freigegeben wurden:
Liste der Verwendungen von Stammzellen, die von den Laboren der FamiCord-Gruppe freigegeben wurden:
Nr.
Quelle
Quellentyp
Diagnose
Medizinbereich
Anwendungsjahr
Therapie
Land
Alter des Empfängers
3801
Apheresis
Autologous
Germ Cell Tumor
Hematology
2021
Standard Therapy
Germany
28
3802
Apheresis
Allogeneic
Hemophagocytic Lymphohistiocytosis (Hlh)
Hematology
2021
Standard Therapy
Poland
23
3803
Apheresis
Allogeneic
Hodgkin Lymphoma
Hematology
2021
Standard Therapy
Poland
41
3804
Apheresis
Allogeneic
Hodgkin Lymphoma
Hematology
2021
Standard Therapy
Poland
40
3805
Apheresis
Allogeneic
Hodgkin Lymphoma
Hematology
2021
Standard Therapy
Poland
27
3806
Apheresis
Allogeneic
Hodgkin Lymphoma
Hematology
2021
Standard Therapy
Poland
19
3807
Apheresis
Allogeneic
Hodgkin Lymphoma
Hematology
2021
Standard Therapy
Poland
26
3808
Apheresis
Allogeneic
Hodgkin Lymphoma
Hematology
2021
Standard Therapy
Poland
32
3809
Apheresis
Allogeneic
Hodgkin Lymphoma
Hematology
2021
Standard Therapy
Germany
21
3810
Apheresis
Allogeneic
Hodgkin Lymphoma
Hematology
2021
Standard Therapy
Germany
37
3811
Apheresis
Autologous
Hodgkin Lymphoma
Hematology
2021
Standard Therapy
Germany
30
3812
Apheresis
Allogeneic
Hodgkin Lymphoma
Hematology
2021
Standard Therapy
Germany
47
3813
Apheresis
Autologous
Hodgkin Lymphoma
Hematology
2021
Standard Therapy
Germany
36
3814
Apheresis
Autologous
Hodgkin Lymphoma
Hematology
2021
Standard Therapy
Germany
30
3815
Apheresis
Allogeneic
Hurler Syndrome
Hematology
2021
Standard Therapy
Poland
2
3816
Apheresis
Allogeneic
Immunodeficiency
Hematology
2021
Standard Therapy
Poland
12
3817
Apheresis
Allogeneic
Leukemia
Hematology
2021
Standard Therapy
Poland
63
3818
Apheresis
Allogeneic
Lymphoma
Hematology
2021
Standard Therapy
Poland
58
3819
Apheresis
Autologous
Mantle Cell Lymphoma
Hematology
2021
Standard Therapy
Germany
66
3820
Apheresis
Autologous
Mantle Cell Lymphoma
Hematology
2021
Standard Therapy
Germany
57
3821
Apheresis
Autologous
Mantle Cell Lymphoma
Hematology
2021
Standard Therapy
Germany
66
3822
Apheresis
Autologous
Mantle Cell Lymphoma
Hematology
2021
Standard Therapy
Germany
57
3823
Apheresis
Autologous
Mantle Cell Lymphoma
Hematology
2021
Standard Therapy
Germany
63
3824
Apheresis
Autologous
Mantle Cell Lymphoma
Hematology
2021
Standard Therapy
Germany
56
3825
Apheresis
Autologous
Mantle Cell Lymphoma
Hematology
2021
Standard Therapy
Germany
65
3826
Apheresis
Allogeneic
Metachromatic Leukodystrophy
Hematology
2021
Standard Therapy
Poland
60
3827
Apheresis
Autologous
Morbus Hodgkin
Hematology
2021
Standard Therapy
Germany
36
3828
Apheresis
Autologous
Morbus Hodgkin
Hematology
2021
Standard Therapy
Germany
50
3829
Apheresis
Autologous
Morbus Hodgkin
Hematology
2021
Standard Therapy
Germany
21
3830
Apheresis
Allogeneic
Mucopolysaccharidosis
Hematology
2021
Standard Therapy
Poland
2
3831
Apheresis
Allogeneic
Multiple Myeloma
Hematology
2021
Standard Therapy
Poland
44
3832
Apheresis
Allogeneic
Multiple Myeloma
Hematology
2021
Standard Therapy
Poland
60
3833
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
70
3834
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
71
3835
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
53
3836
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
51
3837
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
61
3838
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
65
3839
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
62
3840
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
57
3841
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
66
3842
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
50
3843
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
65
3844
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
50
3845
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
47
3846
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
43
3847
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
66
3848
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
56
3849
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
65
3850
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
51
3851
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
61
3852
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
62
3853
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
68
3854
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
70
3855
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
70
3856
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
38
3857
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
61
3858
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
63
3859
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
71
3860
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
52
3861
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
63
3862
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
57
3863
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
68
3864
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
61
3865
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
58
3866
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
57
3867
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
60
3868
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
58
3869
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
67
3870
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
62
3871
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
42
3872
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
61
3873
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
67
3874
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
57
3875
Apheresis
Autologous
Multiple Myeloma
Hematology
2021
Standard Therapy
Germany
68
3876
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
68
3877
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
41
3878
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
60
3879
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
8
3880
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
61
3881
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
62
3882
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
68
3883
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
65
3884
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
56
3885
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
62
3886
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
57
3887
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
47
3888
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
65
3889
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
29
3890
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
66
3891
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
70
3892
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
70
3893
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
59
3894
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
50
3895
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
59
3896
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
28
3897
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
68
3898
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
65
3899
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
54
3900
Apheresis
Allogeneic
Myelodysplastic Syndrome
Hematology
2021
Standard Therapy
Poland
66